Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization

0 avis

Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization

Archive ouverte

Edité par CCSD ; College of American Pathologists -

International audience. The ability to determine ROS1 status has become mandatory for patients with lung adenocarcinoma, as many global authorities have approved crizotinib for patients with ROS1-positive lung adenocarcinoma.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Archive ouverte | Travis, William, D. | CCSD

International audience. This new classification strategy is based on a multidisciplinary approach to diagnosis of lung adenocarcinoma that incorporates clinical, molecular, radiologic, and surgical issues, but it is...

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay

Archive ouverte | Heeke, Simon | CCSD

International audience. Background: Detection of genomic rearrangements, like anaplastic lymphoma kinase (ALK) fusions, is a pivotal requirement in non-small cell lung cancer (NSCLC) for the initiation of a targeted...

Detection of EGFR Variants in Plasma

Archive ouverte | Keppens, Cleo | CCSD

International audience

Chargement des enrichissements...